Olschan Frome Wolosky renders legal opinion
The law firm asserts the 2025 S-3 Registration Statement and the 2026 Prospectus Supplement remain effective. The firm validated the Series of shares covered by the offering.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day